Professional Documents
Culture Documents
THE LOWER
ALVEOLAR RIDGE
& RETROMOLAR
TRIGONE
DR. RAHILA AZIZ
PGR-1ST YEAR
OMFS-PIMS
THIS PRESENTATION WILL
COVER
Anatomy
Incidence & Etiology
Clinical Presentation
Approach to the patient
Cancer treatment modalities
Reconstruction options after surgical Rx of CA LAR/RMT
Take home message
CANCER OF LOWER
ALVEOLAR RIDGE
ANATOMY OF LAR
Part of the mandibular bone that harbors the tooth roots
Bounded,
Definitive Diagnosis
DEPENDING ON RADIOGRAPHS & BIOPSY RESULTS
Treatment Modalities
MDT APPROACH REGARDING SURGERY, RADIOTHERAPY, CHEMOTHERAPY, SURGERY FOLLOWED BY RADIOTHERAPY,
RECONSTRUCTION
MANDIBULAR BONE INVASION
LAR/RMT cancer can invade the underlying cortical bone via foramina (mental, mandibular)
MARGINAL SEGMENTAL
MANDIBULECTOM MANDIBULECTOM
Y Y
ANTERIOR POSTERIOR
MARGINAL MARGINAL
MANDIBULECTOM MANDIBULECTOM
Y Y
ANTERIOR MARGINAL
MANDIBULECTOMY
Is indicated for the mandibular tumors with extensions into FOM or the lingual
gingiva. A circumferential mucosal incision is given which is extended into the
periosteum of the alveolar ridge around the lesion. The dental extractions can be
performed prior to executing the osteotomies. At least 1 cm of mandible must
be left intact to preserve the mandibular stability.
POSTERIOR MARGINAL
MANDIBULECTOMY
Marginal mandibulectomy of the posterior LAR usually requires resection of
the posterior mandibular alveolar ridge as well as the coronoid process in order
to ensure a completely tumor free margin
SEGMENTAL
MANDIBULECTOMY
Segmental mandibulectomy involves the complete
resection of a mandibular segment followed by
reconstruction
Indicated in cases of
Anterior
Lateral
Posterior
CANCER OF RETROMOLAR
TRIGONE
ANATOMY OF RMT
Triangular area bounded by
temporal crest/ATP medially
ramus/buccal mucosa laterally
base posterior to 3rd molar
Lateral border gives attachment to superficial fibers while
medial border gives attachment to deeper fibers of
temporalis M
Lingual nerve, buccal nerve and artery runs close to the
medial border
PMR lies below the RMT which gives attachment to
superior constrictor & buccinator
The lymphatic drainage is important in the early spread of
carcinoma of the oral cavity. The main lymphatic drainage
of the retromolar trigone is into the superior-deep jugular
lymph nodes (level II)
INCIDENCE & ETIOLOGY OF
CA OF RMT
4th most common site for oral cancers with an incidence rate of 8% of
all oral cancers
Etiology is multifactorial. Cigarette smoking and alcohol
consumption remains the most important risk factors. Regular
alcohol consumption is associated with the increased risk of oral
cancer including retromolar subsite of oral cavity.
Betel nut chewing is one of key factors causing the increase in the
incidence of retromolar cancers in Southeast Asia. About 600 million
people are exposed to the habit of betel nut chewing making it the 4 th
most-consumed drug after nicotine, ethanol, and caffeine
CLINICAL PRESENTATION OF
CA OF RMT
Isolated ulcerative or endophytic lesions or may present with
involvement of adjacent structures (buccal mucosa/anterior
tonsillar fossa)
Lower lip splitting & More suitable for posterior retromolar trigone tumors in patients who also present with trismus.
marginal
mandibulectomy
Paramedian Provides good exposure of the retromolar trigone, floor of mouth, and soft palate.
Mandibulotomy &
marginal
mandibulectomy
Upper lip splitting Upper lip splitting can involve only an upper lip split or can extend to a full Weber Ferguson incision.
Segmental Indicated in patients with gross cortical invasion or evidence of bone marrow infiltration of the mandible.
Mandibulotomy
RADIATION THERAPY TECHNIQUES FOR LAR & RMT
CANCER
EBRT is the most common radiotherapy technique used for OC cancers nowadays
RT different directions
• Is a form of 3D-CRT
modulated RT • Along with shaping the beam and aiming them at the
tumor, the intensity/strength of the beams can be adjusted
to limit the dose reaching to normal tissues
Proton beam • Proton beam is used for radiation instead of the x-rays
RT
DIFFERENT TREATMENT SCHEDULES
FOR EBRT
Standard EBRT for cancers of oral cavity is usually given in daily doses that is
5 days a week for about 7 weeks. Other schedules are :